4//SEC Filing
Seely Lynn 4
Accession 0001415889-25-008509
CIK 0001806952other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 6:59 PM ET
Size
5.1 KB
Accession
0001415889-25-008509
Insider Transaction Report
Form 4
Seely Lynn
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2025-03-14$0.61/sh+175,000$106,190→ 712,500 total
Footnotes (1)
- [F1]The price reported above reflects the weighted average price of the shares purchased. These shares were purchased in multiple transactions at prices ranging from $0.59980 to $0.62020, inclusive. Upon request from the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this range.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001327111
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 6:59 PM ET
- Size
- 5.1 KB